Study could serve as guidepost for developing new therapies for Alzheimer's disease

Study could serve as guidepost for developing new therapies for Alzheimer's disease
In a major breakthrough, researchers at Massachusetts General Hospital (MGH) have discovered how amyloid beta--the neurotoxin believed to be at the root of Alzheimer's disease (AD)--forms in axons and related structures that connect neurons in the brain, where it causes the most damage.
Their findings, published in
Cell Reports, could serve as a guidepost for developing new therapies to prevent the onset of this devastating neurological disease.
Among his many contributions to research on AD, Rudolph Tanzi, PhD, vice chair of Neurology and co-director of the McCance Center for Brain Health at MGH, led a team in 1986 that discovered the first Alzheimer's disease gene, known as APP, which provides instructions for making amyloid protein precursor (APP).

Related Keywords

Massachusetts ,United States ,Raja Bhattacharyya ,Dora Kovacs ,Rudolph Tanzi ,Doo Yeon Kim ,Emily Henderson ,Mccance Center ,Brain Health ,Massachusetts General Hospital ,Cell Reports ,Vice Chair ,Massachusetts General ,Brain ,Nerve ,Lzheimer 39s Disease ,Fell ,Gene ,Hospital ,Medical School ,Neurological Disease ,Eurology ,Euron ,Eurons ,Protein ,Eceptor ,Research ,மாசசூசெட்ஸ் ,ஒன்றுபட்டது மாநிலங்களில் ,ருடால்ப் டான்சி ,டூ யோன் கிம் ,எமிலி ஹென்டர்சன் ,ம்க்க்யாந்ஸ் மையம் ,மூளை ஆரோக்கியம் ,மாசசூசெட்ஸ் ஜநரல் மருத்துவமனை ,செல் அறிக்கைகள் ,துணை நாற்காலி ,மாசசூசெட்ஸ் ஜநரல் ,மூளை ,எனே ,